A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

China-Japan Friendship Hospital, Beijing

Peking University Third Hospital, Beijing

The First Affiliated Hospital of Dalian Medical University, Dalian

Jilin Cancer Hospital, Changchun

The Affiliated Tumor Hospital of Harbin Medical University, Harbin

Shanghai Sixth people's hospital, Shanghai

Fudan University Shanghai Cancer Center, Shanghai

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

Nantong Tumor Hospital, Nantong

Linyi Cancer Hospital, Linyi

Tianjin People's Hospital, Tianjin

Tianjin Medical University General Hospital, Tianjin

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

Sir Run Run Shaw Hospital, Zhejiang University School of Medical, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

Fujian Medical University Union Hospital, Fuzhou

Henan Cancer Hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Cancer Center of Guangzhou Medical University, Guangzhou

Sun Yai-Sen Memorial Hospital, Sun Yai-Sen University, Guangzhou

Nanfang Hospital, Guangzhou

Hainan General Hospital, Hainan

West China Hospital, Sichuan University, Chengdu

The First Hospital of Lanzhou University, Lanzhou

The Forth Hospital of Hebei Medical University, Shijiazhuang